Hammerness, Paul

A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Harpold, T., Dunkel, S., Dougherty, M., Aleardi, M., & Spencer, T. (2006) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 267

Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review

Chan, E., Fogler, J. M., & Hammerness, P. G. (2016) · JAMA

Attention Deficit Hyperactivity DisorderBehavioral and Psychological Studies

Cited by 261

A randomized controlled trial of cognitive behavioral therapy for ADHD in medication‐treated adolescents

Sprich, S. E., Safren, S. A., Finkelstein, D., Remmert, J. E., & Hammerness, P. (2016) · Journal of Child Psychology and Psychiatry

Attention Deficit Hyperactivity DisorderBehavioral and Psychological Studies

Cited by 114

An Evidence-Based Systematic Review of Aloe vera by the Natural Standard Research Collaboration

Ulbricht, C., Armstrong, J., Basch, E., Basch, S., Bent, S., Dacey, C., Dalton, S., Foppa, I., Giese, N., Hammerness, P., et al. (2008) · Journal of Herbal Pharmacotherapy

Phytochemistry and biological activity of medicinal plantsComplementary and Alternative Medicine Studies

Cited by 84

A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

Biederman, J., Mick, E., Surman, C., Doyle, R., Hammerness, P., Kotarski, M., & Spencer, T. (2010) · Journal of Clinical Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 76

The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: A randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm

Biederman, J., Fried, R., Hammerness, P., Surman, C., Mehler, B., Petty, C. R., Faraone, S. V., Miller, C., Bourgeois, M., Meller, B., et al. (2012) · Journal of Psychiatric Research

Attention Deficit Hyperactivity DisorderTraffic and Road Safety

Cited by 60

Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder

Hammerness, P., Wilens, T., Mick, E., Spencer, T., Doyle, R., McCreary, M., Becker, J., & Biederman, J. (2009) · The Journal of Pediatrics

Attention Deficit Hyperactivity DisorderBlood Pressure and Hypertension Studies

Cited by 57

An Open Study of Adjunct OROS-Methylphenidate in Children and Adolescents Who Are Atomoxetine Partial Responders: I. Effectiveness

Wilens, T. E., Hammerness, P., Utzinger, L., Schillinger, M., Georgiopoulous, A., Doyle, R. L., Martelon, M., & Brodziak, K. (2009) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 54

Brain Biochemical Effects of Methylphenidate Treatment Using Proton Magnetic Spectroscopy in Youth with Attention‐Deficit Hyperactivity Disorder: A Controlled Pilot Study

Hammerness, P., Biederman, J., Petty, C., Henin, A., & Moore, C. M. (2012) · CNS Neuroscience & Therapeutics

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 53

Do stimulants improve functioning in adults with ADHD?

Surman, C. B. H., Hammerness, P. G., Pion, K., & Faraone, S. V. (2013) · European Neuropsychopharmacology

Attention Deficit Hyperactivity DisorderNeuroethics, Human Enhancement, Biomedical Innovations

Cited by 47

Do Stimulants Reduce the Risk for Cigarette Smoking in Youth with Attention-Deficit Hyperactivity Disorder? A Prospective, Long-Term, Open-Label Study of Extended-Release Methylphenidate

Hammerness, P., Joshi, G., Doyle, R., Georgiopoulos, A., Geller, D., Spencer, T., Petty, C. R., Faraone, S. V., & Biederman, J. (2013) · The Journal of Pediatrics

Attention Deficit Hyperactivity DisorderSmoking Behavior and Cessation

Cited by 39

A Controlled Trial of the Methylphenidate Transdermal System on Before-School Functioning in Children With Attention-Deficit/Hyperactivity Disorder

Wilens, T. E., Hammerness, P., Martelon, M., Brodziak, K., Utzinger, L., & Wong, P. (2010) · The Journal of Clinical Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 30

The Effects of Lisdexamfetamine Dimesylate on Driving Behaviors in Young Adults With ADHD Assessed With the Manchester Driving Behavior Questionnaire

Biederman, J., Fried, R., Hammerness, P., Surman, C., Mehler, B., Petty, C. R., Faraone, S. V., Miller, C., Bourgeois, M., Meller, B., et al. (2012) · Journal of Adolescent Health

Attention Deficit Hyperactivity DisorderTraffic and Road Safety

Cited by 24

A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder

Hammerness, P., Zusman, R., Systrom, D., Surman, C., Baggish, A., Schillinger, M., Shelley-Abrahamson, R., & Wilens, T. E. (2013) · The World Journal of Biological Psychiatry

Attention Deficit Hyperactivity DisorderCardiovascular Function and Risk Factors

Cited by 15

Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD

Hammerness, P., Fried, R., Petty, C., Meller, B., & Biederman, J. (2014) · Child Neuropsychology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 14

Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study

Hammerness, P., Doyle, R., Kotarski, M., Georgiopoulos, A., Joshi, G., Zeitlin, S., & Biederman, J. (2009) · European Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 8